Jin Medical International (ZJYL) Finished Goods (2022 - 2025)

Jin Medical International (ZJYL) has reported Finished Goods for 4 consecutive years, with $915839.0 the latest figure, recorded in Q3 2025.

• Quarterly Finished Goods fell 33.02% year-over-year to $915839.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $915839.0 (down 33.02% YoY) and the FY2025 annual result came in at $915839.0, down 33.02% from the prior year.
• Finished Goods rose to $915839.0 in Q3 2025 per ZJYL's latest filing, from $888900.0 in the prior quarter.
• Over the last five years, Finished Goods for ZJYL reached as high as $2.1 million in Q3 2022 and fell as low as $417466.0 in Q1 2024.
• A 4-year average of $1.1 million and a median of $915839.0 in 2025 frame the typical range for Finished Goods.
• Annual changes were most pronounced in 2024 — Finished Goods slumped 71.85% — and 2025, when it surged 112.93%.
• Year by year, Finished Goods stood at $2.1 million in 2022, then tumbled by 59.97% to $820949.0 in 2023, then soared by 66.57% to $1.4 million in 2024, then tumbled by 33.02% to $915839.0 in 2025.
• According to Business Quant data, Finished Goods over the past three periods registered $915839.0, $888900.0, and $1.4 million for Q3 2025, Q1 2025, and Q3 2024 respectively.